Publication|Articles|May 1, 2003
The American Journal of Managed Care
- May 2003
- Volume 9
- Issue 5
Effect of Off-Label Use of Oncology Drugs on Pharmaceutical Costs: The Rituximab Experience
Author(s)Darren Kocs, MD, MHSA, A. Mark Fendrick, MD
Advertisement
Articles in this issue
almost 23 years ago
Lansoprazole Overutilization: Methods for Step-Down Therapyalmost 23 years ago
Reducing Costs and Improving Outcomes of Percutaneous Coronary InterventionsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
How Do GLP-1 Agonists Fit Into Stroke Care?
3
5 Things to Know About the Oral GLP-1 Era
4
Addressing Disparities at Every Step of the Stroke Care Pathway: Luke Messac, MD, PhD
5
